Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
This prospective, single-centre, open-label, randomized study aims to determine whether coordinated care in administering protective vaccinations (against Respiratory Syncytial Virus (RSV) and influenza) impacts the prognosis of patients with chronic heart failure.

The main question it aims to answer is:

• Does coordinated care through vaccinations improve the prognosis of patients with chronic heart failure?
- EligibilityCriteria: Inclusion Criteria:  Age above 18 years Willingness to provide informed consent for participation in the study Diagnosis of heart failure No previous vaccination against RSV or influenza  Exclusion Criteria:  History of an anaphylactic reaction to vaccination Hypersensitivity to any component of the vaccine Receipt of vaccination against RSV or influenza in the current infectious Active infection Pregnancy - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult